Patient and program characteristics which influence screening for bone mineral disease in people with Cystic Fibrosis
Measuring how the drug elexacaftor/tezacaftor/ivacaftor affects the muscles of breathing, using dynamic chest radiography
Elexacaftor-tezacaftor-ivacaftor provides continued health improvement in lung transplant candidates with cystic fibrosis
Exploring health care provider attitudes and perspectives related to men’s sexual and reproductive health in cystic fibrosis
